scholarly journals Coformulation with Tattoo Ink for Immunological Assessment of Vaccine Immunogenicity in the Draining Lymph Node

2021 ◽  
pp. ji2001299
Author(s):  
Isaac M. Barber-Axthelm ◽  
Hannah G. Kelly ◽  
Robyn Esterbauer ◽  
Kathleen M. Wragg ◽  
Anne M. Gibbon ◽  
...  
2020 ◽  
Author(s):  
Isaac M Barber-Axthelm ◽  
Hannah G Kelly ◽  
Robyn Esterbauer ◽  
Kathleen Wragg ◽  
Anne Gibbon ◽  
...  

AbstractCharacterisation of germinal centre B and T cell responses yields critical insights into vaccine immunogenicity. Non-human primates are a key pre-clinical animal model for human vaccine development, allowing both lymph node and circulating immune responses to be longitudinally sampled for correlates of vaccine efficacy. However, patterns of vaccine antigen drainage via the lymphatics after intramuscular immunisation can be stochastic, driving uneven deposition between lymphoid sites, and between individual lymph nodes within larger clusters. In order to improve the accurate isolation of antigen-exposed lymph nodes during biopsies and necropsies, we developed and validated a method for co-formulating candidate vaccines with tattoo ink, which allows for direct visual identification of vaccine-draining lymph nodes and evaluation of relevant antigen-specific B and T cell responses by flow cytometry. This approach improves the assessment of vaccine-induced immunity in highly relevant non-human primate models.


2005 ◽  
Vol 65 (24) ◽  
pp. 11639-11648 ◽  
Author(s):  
Virginie Carrière ◽  
Renaud Colisson ◽  
Carine Jiguet-Jiglaire ◽  
Elisabeth Bellard ◽  
Gérard Bouche ◽  
...  

2012 ◽  
Vol 5 (2) ◽  
pp. 250-263 ◽  
Author(s):  
Michel Obeid ◽  
Jean‐François Franetich ◽  
Audrey Lorthiois ◽  
Audrey Gego ◽  
Anne Charlotte Grüner ◽  
...  

Author(s):  
Cora Waldstein ◽  
Trevor Moodie ◽  
Simon Ashworth ◽  
Verity Ahern ◽  
Kirsty Stuart ◽  
...  

Author(s):  
Susan N. Thomas

Immunotherapy-based approaches for cancer treatment are of increasing clinical interest. Principles of drug delivery and the emerging field of material design for immunomodulation might hold significant promise for novel approaches in cancer immunotherapy since biomaterials engineering strategies enable enhanced delivery of immune modulatory agents to tissues and cells of the immune system1. One tissue of significant clinical interest in a cancer setting is the tumor-draining lymph node (TDLN), which participates in cancer progression by enabling both metastatic dissemination as well as tumor-induced immune escape. Hence, the TDLN represents a novel target for drug delivery schemes for cancer immunotherapy. We hypothesize that targeted delivery of adjuvants (Adjs) to the TDLN using a biomaterials-based approach might promote antitumor immunity and hinder tumor growth.


Sign in / Sign up

Export Citation Format

Share Document